Azenta (NASDAQ:AZTA) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Azenta (NASDAQ:AZTA) issued its quarterly earnings results on Wednesday. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.03, Zacks reports. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%.

Azenta Stock Performance

AZTA opened at $53.76 on Thursday. The company’s 50 day moving average is $50.35 and its 200-day moving average is $49.07. Azenta has a 1-year low of $38.82 and a 1-year high of $67.77.

Insider Buying and Selling

In other news, CFO Herman Cueto sold 712 shares of the business’s stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $40.07, for a total transaction of $28,529.84. Following the sale, the chief financial officer now directly owns 23,892 shares in the company, valued at approximately $957,352.44. The trade was a 2.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director William L. Cornog acquired 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was acquired at an average price of $39.60 per share, with a total value of $495,000.00. Following the acquisition, the director now owns 14,755 shares in the company, valued at $584,298. The trade was a 554.32 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 1,423 shares of company stock worth $57,020 in the last three months. 10.62% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

AZTA has been the subject of several analyst reports. Needham & Company LLC upped their price target on shares of Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a report on Thursday. Stephens restated an “overweight” rating and set a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.